Contact Person
    Nicole Mastrell

    Event Manager & PA to CEO
    Email: nm@mva.org
    Phone: (M) +45 6141 8634
    Linkedin

    MicroMAX User Meeting

    Welcome to the MicroMAX User Meeting at the Novo Nordisk Foundation Center for Protein Research in Copenhagen, Denmark.

    The meeting is centred around the future MicroMAX beamline at MAX IV Laboratory that will open to users at the end of 2022. The programme includes scientific presentations illustrating the science that will be done at MicroMAX and ample time for discussions about what you would like to be able to do at MicroMAX as a future user.

    Meeting is free of charge but registration is mandatory. To register: https://indico.maxiv.lu.se/event/1244/ (or see maxiv.lu.se/micromax)

    Date: 2 March 2020
    Time: 12:00 – 17:00
    Venue: ”Faculty Club” in building 16 at Panum, Room number 16.6.16. Novo Nordisk Foundation Center for Protein Research, Blegdamsvej 3B, DK-2200 Copenhagen N

    READ MORE & SIGN UP

    Programme

    12:00

    Sandwich lunch

    12:30

    Eriko Nango, Kyoto University, Japan, “Time-resolved serial femtosecond crystallography at SACLA: Current status and future prospects”

    13:10

    Arwen Pearson, Universität Hamburg, Germany, “The T-REXX endstation for time-resolved serial synchrotron crystallography at PETRA III”

    13:50

    Discussion – MicroMAX and time-resolved crystallography

    14:10

    Coffee

    14:30

    Azadeh Shahsavar, Aarhus University, “Structure determination of a human neurotransmitter transporter by serial synchrotron crystallography”

    14:50

     Thomas Lykke-Møller Sørensen, Aarhus University, “In situ crystallography – experience and possibilities”

    15:10

    Discussion – what a microfocus beamline like MicroMAX can do

    15:30

    MicroMAX: Planned performance, experimental setups & facilities

    16:00

    Richard Neutze, University of Gothenburg, “Introduction to general discussion”

    16:20

    Discussion – MicroMAX capabilities & priorities

    17:00

    End of meeting

    The MicroMAX beamline is funded by Novo Nordisk Fonden